Tag: (ASX:CAN)
CSIRO now set to develop new medicinal cannabis products
CSIRO will work hand-in-hand with local manufacturers to develop new medicinal cannabis therapeutics – a move that will also make room in the local...
Cann Group moves to acquire Satipharm with Share Sale Agreement
The acquisition will fast-track the development of medicinal cannabis delivery systems and formulations to be sold over-the-counter across Australia.
Cann Group Limited (ASX:CAN) has signed...
Featured Article
The economic forces driving manufacturing’s next cycle
Australia’s manufacturing sector entered 2026 with improving momentum, but renewed global disruption is again testing resilience across the industry.
